skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder

Epidemiology and psychiatric sciences, 2017-02, Vol.26 (1), p.22-36 [Peer Reviewed Journal]

Copyright © Cambridge University Press 2016 ;Cambridge University Press 2016 2016 Cambridge University Press ;ISSN: 2045-7960 ;EISSN: 2045-7979 ;DOI: 10.1017/S2045796016000020 ;PMID: 26810628

Full text available

Citations Cited by
  • Title:
    Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder
  • Author: Kessler, R. C. ; van Loo, H. M. ; Wardenaar, K. J. ; Bossarte, R. M. ; Brenner, L. A. ; Ebert, D. D ; de Jonge, P. ; Nierenberg, A. A. ; Rosellini, A. J. ; Sampson, N. A. ; Schoevers, R. A. ; Wilcox, M. A. ; Zaslavsky, A. M.
  • Subjects: Mental disorders ; Mental health care ; Patients ; Special ; Special Article
  • Is Part Of: Epidemiology and psychiatric sciences, 2017-02, Vol.26 (1), p.22-36
  • Description: Clinicians need guidance to address the heterogeneity of treatment responses of patients with major depressive disorder (MDD). While prediction schemes based on symptom clustering and biomarkers have so far not yielded results of sufficient strength to inform clinical decision-making, prediction schemes based on big data predictive analytic models might be more practically useful. We review evidence suggesting that prediction equations based on symptoms and other easily-assessed clinical features found in previous research to predict MDD treatment outcomes might provide a foundation for developing predictive analytic clinical decision support models that could help clinicians select optimal (personalised) MDD treatments. These methods could also be useful in targeting patient subsamples for more expensive biomarker assessments. Approximately two dozen baseline variables obtained from medical records or patient reports have been found repeatedly in MDD treatment trials to predict overall treatment outcomes (i.e., intervention v. control) or differential treatment outcomes (i.e., intervention A v. intervention B). Similar evidence has been found in observational studies of MDD persistence-severity. However, no treatment studies have yet attempted to develop treatment outcome equations using the full set of these predictors. Promising preliminary empirical results coupled with recent developments in statistical methodology suggest that models could be developed to provide useful clinical decision support in personalised treatment selection. These tools could also provide a strong foundation to increase statistical power in focused studies of biomarkers and MDD heterogeneity of treatment response in subsequent controlled trials. Coordinated efforts are needed to develop a protocol for systematically collecting information about established predictors of heterogeneity of MDD treatment response in large observational treatment studies, applying and refining these models in subsequent pragmatic trials, carrying out pooled secondary analyses to extract the maximum amount of information from these coordinated studies, and using this information to focus future discovery efforts in the segment of the patient population in which continued uncertainty about treatment response exists.
  • Publisher: Cambridge, UK: Cambridge University Press
  • Language: English;Italian
  • Identifier: ISSN: 2045-7960
    EISSN: 2045-7979
    DOI: 10.1017/S2045796016000020
    PMID: 26810628
  • Source: ProQuest One Psychology
    Journals@Ovid Open Access Journal Collection Rolling
    PubMed Central
    ProQuest Central

Searching Remote Databases, Please Wait